Enzo Biochem Appoints Jason Apter as Chief Executive Officer

Company

Location

About

Enzo Life Sciences, Inc. is a global leader in labeling and detection technologies, serving the life sciences research, drug discovery, drug development, and diagnostic markets for over 45 years. Founded in 1976 and based in Farmingdale, New York, the company focuses on enabling scientific innovation through its Life Sciences division, which supports a variety of applications from DNA analysis to whole cell and tissue analysis. The company offers a diverse product portfolio that includes antibodies, proteins, peptides, small molecules, genomic probes, assays, and labeling probes. These high-quality products are rigorously validated and are essential for target identification, gene expression analysis, protein biochemistry, and more. Enzo Life Sciences also provides custom manufacturing services, assay and validation testing, and GMP-certified services to assist biopharmaceutical and biotechnology companies in their drug development processes. With over 500 patents and more than 175,000 scientific citations, Enzo Life Sciences is committed to innovation and scientific rigor. The company emphasizes a customer-focused approach, positioning itself as "Scientists Enabling Scientists®" to support researchers in advancing scientific discovery.